Vitamin D and Omega-3 Trial to Prevent and Treat Diabetic Kidney Disease [ANCILLARY OF 700049031]

Trial Profile

Vitamin D and Omega-3 Trial to Prevent and Treat Diabetic Kidney Disease [ANCILLARY OF 700049031]

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Mar 2018

At a glance

  • Drugs Colecalciferol (Primary) ; Omega-3-acid ethyl esters (Primary)
  • Indications Diabetic nephropathies
  • Focus Therapeutic Use
  • Acronyms VITAL-DKD
  • Most Recent Events

    • 16 Mar 2018 Status changed from active, no longer recruiting to completed.
    • 10 Jun 2017 Biomarkers information updated
    • 13 May 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Dec 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top